Yetiştiriciliği Yapılan Levrek Balıklarında, Dicentrarchus labrax (Linnaeus, 1758) Lernanthropus kroyeri (Van Beneden, 1851) (Lernanthropidae) Enfestasyonlarının Tedevisinde Emamektin Benzoatın Etkisi
Bu çal›flmada, levrek bal›klar›nda (Dicentrarchus labrax L.) görülen Lernanthropus kroyeri (van Beneden, 1851) enfestasyonlar›n›n tedavisinde kullan›lan emamektin benzoat›n etkisinin de¤erledirilmesi amac›yla farkl› dozlar uygulanan befl grup oluflturuldu. Emamektin benzoat bu gruplara 7 gün süreyle yem içinde 0 (kontrol), 10, 25, 50 and 100 µg kg-1 dozlar›nda verildi. Denemenin yap›ld›¤› suyun s›cakl›¤› 16-16,5 °C olarak tespit edildi. Emamektin benzoate ile yap›lan tedavinin L. kroyeri’nin larva ve eriflkin evrelerine karfl› etkili oldu¤u bulundu. Tedavinin uyguland›¤› süre içinde 10, 25, 50 and 100 µg kg-1 dozlar›nda ilaç verilen gruplarda parazit say›s›, s›ras›yla % 55, 50, 43 and 74 azal›rken, ayn› süre içinde control grubunda parazit say›s›n›n % 8 artt›¤› belirlendi. Denenen bütün dozlarda, emamektin benzoate ile yap›lan tedavi nedeniyle gruplar aras›nda büyüme ve ölüm oran› bak›m›ndan fark bulunmad› (P > 0,05).
The Effect of Emamectin Benzoate in the Control of Lernanthropus kroyeri (van Beneden, 1851) (Lernanthropidae) Infestations in Cultured Sea Bass, Dicentrarchus labrax (Linnaeus, 1758)
Five different dose groups were formed to evaluate the efficacy of emamectin benzoate as a treatment for Lernanthropus kroyeri (van Beneden, 1851) infestation in cultured sea bass Dicentrarchus labrax (L.). Emamectin benzoate was administered in-feed at doses of 0 (control), 10, 25, 50, and 100 µg kg-1 biomass day-1 for 7 consecutive days. Parasites were counted on days 7, 14, and 21, and comparisons were made to untreated control fish. Seawater temperature was 16-16.5 °C. Treatment with emamectin benzoate was effective against larval and mature stages of L. kroyeri. The number of L. kroyeri in the control fish increased by 8% during the 21 days of the study, whereas their number decreased in the treated fish by 55%, 50%, 43%, and 74% at the dose of 10, 25, 50, and 100 µg kg-1, respectively. No differences were observed with respect to growth between the treatment groups and the control group, and no mortality was observed at the end of the study.